Submitting Comments on the Inflation Reduction Act’s Medicare Drug Price Negotiation Program Guidance
The Inflation Reduction Act of 2022 establishes the Medicare Drug Price Negotiation Program, which permits the government to negotiate drug prices for certain high expenditure, single source Medicare Part B and Part D drugs.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year